From fungus fighter to cancer slayer: itraconazole as a multifaceted candidate for drug-resistant prostate cancer
{{output}}
Background: Metastatic castration-resistant prostate cancer (mCRPC) remains a lethal disease state with limited durable responses to existing therapies, including taxane-based chemotherapy. Resistance mechanisms are multifactoria... ...
